NCT03391622View on ClinicalTrials.gov

Thrombin Generation Values and Percutaneous Coronary Intervention Results.

CompletedOBSERVATIONAL
Enrollment

128

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

August 30, 2020

Study Completion Date

August 30, 2020

Conditions
Coagulation DisorderIschemic Heart DiseaseArtery Coronary Stenosis
Interventions
DEVICE

Calibrated Automated Thrombogram

blood samples will be collected . Thrombin generation in platelet-poor plasma will be measured by means of the Calibrated Automated Thrombogram (CAT).

Trial Locations (1)

1834111

Hemek medical center, Afula

All Listed Sponsors
lead

HaEmek Medical Center, Israel

OTHER

NCT03391622 - Thrombin Generation Values and Percutaneous Coronary Intervention Results. | Biotech Hunter | Biotech Hunter